Telaprevir, a hepatitis C treatment being developed by Vertex Pharmaceuticals Inc, led to a 75% rate of sustained viral response (SVR) in a pivotal trial of previously untreated patients, the company said on Tuesday. Reuters Health Information
In a systematic review, weight loss or increased physical activity reduced liver fat and improved glucose control and insulin sensitivity in patients with nonalcoholic fatty liver disease. br / iReuters Health Information/i
Although home parenteral nutrition (HPN) is still the primary option for treating intestinal failure, intestinal transplantation can be a life-saving alternative, according to a 3-year prospective study by European researchers, published in the July issue of Gastroenterology. Reuters Health Information
